A Phase IB/II Clinical Study of SHR-9839 for Injection Combined With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors
A phase 1/2 trial of SHR-A1921, SHR-A2009, Aumolertinib, Pemetrexed, Carboplatin and Adebrelimab in advanced solid tumours, run by Shanghai Hengrui Pharmaceutical Co., Ltd., now recruiting.
Overview
A Phase IB/II Clinical Study of SHR-9839 for Injection Combined With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors is a phase 1/2 interventional study registered as NCT06474455 by Shanghai Hengrui Pharmaceutical Co., Ltd., with 156 participants planned, started 2024-07-02 and due to reach its primary completion in 2029-06. Interventions recorded: SHR-9839 for Injection, SHR-A1921 for Injection, SHR-A2009 for Injection, Almonertinib Mesilate Tablets, Pemetrexed Disodium for Injection and Carboplatin for injection.
Similar pages
not linked directly; found by shared links- TrialStudy of SHR-A1921 in Combination With Other Anti-cancer Agents in Patients With Advanced Solid Tumors
Shares SHR-A1921, Jiangsu Hengrui Pharmaceuticals, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialStudy of HRS-8080 or SHR-A2009 Combined With Anti-tumor Therapy in Patients With Unresectable or Metastatic Breast Cancer
Shares SHR-A2009, Adebrelimab, Jiangsu Hengrui Pharmaceuticals, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Study of HRS-4642 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
Shares Adebrelimab, Pemetrexed, Jiangsu Hengrui Pharmaceuticals, Carboplatin and the tag pipeline.
- TrialA Trial of SHR-7787 Injection Combined With Other Anti-tumor Drugs in Patients With Malignant Solid Tumors
Shares Adebrelimab, Jiangsu Hengrui Pharmaceuticals, Carboplatin, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Trial of SHR-4849 Combined With Other Antitumor Drugs in Patients With Malignant Solid Tumors
Shares Adebrelimab, Jiangsu Hengrui Pharmaceuticals, Carboplatin, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Phase II Clinical Study of FH-006 for Injection Combined With Other Anticancer Therapies in Subjects With Lung Cancer
Shares Adebrelimab, Jiangsu Hengrui Pharmaceuticals, Carboplatin, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Study of SHR-7367 With Anti-tumor Agents in Patients With Solid Tumors
Shares Adebrelimab, Jiangsu Hengrui Pharmaceuticals, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialPhase I/II Clinical Study of SHR-1501 Combined With Adbelizumab in Patients With Malignant Tumors
Shares Adebrelimab, Jiangsu Hengrui Pharmaceuticals, Metastatic cancer (cancer that has spread) and the tag pipeline.